ZED-1227 is a novel, potent, selective and orally bioactive tissue transglutaminase (TGM2) inhibitor (IC50 of 45 nM) with the potential to be used for the treatment of celiac disease. It can block inflammation-induced TG2 expression and activity.
纯度:≥98%
CAS:1542132-88-6